Stocks
Lisata Therapeutics, Inc.LSTA
NASDAQHealthcareBiotechnology$1.00
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing targeted therapies for solid tumors, with a lead candidate designed to enhance the delivery of chemotherapy to cancer cells. Its pipeline focuses on pancreatic cancer and other difficult-to-treat indications, and investors track it for upcoming clinical trial readouts and regulatory milestones.
52W Range: $0.96-$5.07
Congressional Interest in Lisata Therapeutics, Inc. (LSTA)
No congressional trades have been disclosed for Lisata Therapeutics, Inc. (LSTA) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading LSTA?
No congressional trades found for this stock.